98%
921
2 minutes
20
Recent reports have suggested that cytomegalovirus (CMV) infection may contribute to risk of cardiovascular disease. However, relationship between CMV infection and unstable angina (UA) is controversial and studies about this subject in Iran and even region are lacking. The aim of this study was to determine whether unstable angina is related to seropositivity to chronic cytomegalovirus infection. We measured serum CMV IgG levels in a case control study participants in CCU in Razi Hospital, Ahvaz, Iran, from 2004 to 2005. Blood samples were drawn during study period from 96 patients (mean age 56 years) with UA according to American Heart Association Criteria and from 96 participants free of cardiovascular disease (mean age 58 years) and stored at -20°C. Blood samples of patients were undertaken for investigating the specific anti CMV-IgG by ELISA method. Data were analyzed in SPSS 11.5 by using chi square test, odds ratios (OR) with 95% confidence intervals (CI). Ninety three percent of patients with unstable angina and 96.7% in the control group presented a positive anti CMV-IgG. Odds ratio was 0.52 with 95% CI: 0.10 to 2.42. There was no significant correlation between CMV-IgG positivity and unstable angina (P>0.05). There was also no differences in CMV-IgG positivity in clinical groups of UA (P>0.05). The relationship between seropositivity of CMV-IgG and unstable angina has been restituted by the results of this study. However, further population based cohort studies for relationship between CMV infection and coronary artery disease must be conducted.
Download full-text PDF |
Source |
---|
PLoS One
September 2025
Cardiovascular Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Background: There is emerging evidence suggesting that vitamin D and fibrinogen play contrasting roles in ACS pathophysiology and their combined impact, expressed as the vitamin D/fibrinogen ratio, can be a potential biomarker for ACS severity. This study aimed to investigate the relationship between vitamin D, fibrinogen, and their ratio with ACS types, and assess their potential as risk stratification biomarkers.
Methods: This multicenter observational study was conducted in tertiary care hospitals in Afghanistan, Egypt, and Pakistan, including 300 ACS patients.
Intern Med
September 2025
Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Japan.
Objective The intracoronary acetylcholine (ACh) provocation test is an invasive standard for diagnosing coronary spastic angina (CSA)/vasospastic angina. Although the guidelines recommend incremental doses of ACh, the clinical relevance of the significant response to lower ACh doses is unclear. Methods From April 2012 to June 2024, 636 patients with no significant epicardial coronary disease undergoing intracoronary ACh provocation testing for the diagnosis of CSA were included.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2025
Department of Cardiology, Kettering General Hospital, University hospitals of Northamptonshire, Kettering, Northamptonshire, UK.
We report the management of a 59-year-old male with genetically confirmed porphyria who underwent two percutaneous coronary interventions (PCI) using Everolimus and Sirolimus-eluting intracoronary devices for acute coronary syndromes. The first PCI involved treatment of mid-LAD disease with a SYNERGY Everolimus-eluting stent. Two years later, the patient re-presented with unstable angina and underwent further PCI using an Xience Everolimus-eluting stent for LAD and a Sirolimus-coated drug-eluting balloon for a CTO in first diagonal branch.
View Article and Find Full Text PDFCureus
July 2025
Department of Internal Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Acute coronary syndrome (ACS) is a critical medical condition characterized by a sudden reduction in blood flow to cardiac muscle. This condition encompasses unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI), requiring rapid diagnosis and intervention for optimal outcomes. Despite advances in treatment, ACS remains a leading cause of morbidity and mortality worldwide.
View Article and Find Full Text PDFJ Am Coll Cardiol
August 2025
Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona (FE), Italy.
Background: The clinical benefit of routine coronary computed tomography angiography (CCTA) after percutaneous coronary intervention (PCI) for unprotected left main (LM) disease is uncertain.
Objectives: The authors evaluated whether CCTA-guided follow-up improves clinical outcomes vs symptoms- or ischemia-driven care after LM PCI.
Methods: PULSE was a prospective, multicenter, open-label randomized trial.